eye health – Web Xpress http://web-xpress.com/ Mon, 18 Apr 2022 12:20:04 +0000 en-US hourly 1 https://wordpress.org/?v=5.9.3 https://web-xpress.com/wp-content/uploads/2021/10/icon-9-150x150.png eye health – Web Xpress http://web-xpress.com/ 32 32 Technology in optometry: how it has benefited the industry https://web-xpress.com/technology-in-optometry-how-it-has-benefited-the-industry/ Sun, 20 Mar 2022 01:10:53 +0000 https://web-xpress.com/technology-in-optometry-how-it-has-benefited-the-industry/ Technology has come a long way in the optometry industry. It has changed the way optometrists do things and has improved patient outcomes as well. As a result, more people were able to reach better eye health because of optometry. What is optometry? Optometry is a branch of medicine that deals with the eyes and […]]]>

Technology has come a long way in the optometry industry. It has changed the way optometrists do things and has improved patient outcomes as well. As a result, more people were able to reach better eye health because of optometry.

What is optometry?

Optometry is a branch of medicine that deals with the eyes and vision. Optometrists are eye care professionals who assess, diagnose, treat and manage diseases, disorders and conditions of the eye and visual system.

Technology played a big role in optometry. It has helped optometrists do their jobs better and has also helped improve patient outcomes. There are many types of technologies that have been beneficial to optometry. Some of the most common include:

Electronic Health Records (EHR)

EHRs have helped optometrists more easily track patient medical histories. This is important because it can help them make informed decisions about treatment plans and also helps them track progress over time.

Computerized refraction systems

Computerized refractive systems have helped optometrists test patients’ vision more accurately. This is important because it helps them prescribe the right glasses or contact lenses for each patient.

Eye tracking devices

Eye tracking devices have helped optometrists more effectively diagnose and treat eye conditions. This is important because it can help improve patient outcomes and also helps optometrists save time on diagnosis and treatment.

Due to these and many other benefits, technology has played a significant role in improving optometry and helping to improve the industry as a whole.

For example, glasses for the visually impaired can now be done in less than an hour. Indeed, technology has allowed the development of new methods and new materials to be used in optometry.

Additionally, technology has also enabled the development of new treatments for eye conditions. For example, there are now treatments available for conditions such as macular degeneration and glaucoma that were unavailable in the past.

All of these advancements have helped to improve the optometry industry and have resulted in more people having better eye health. Thanks to technology, optometry is able to provide better care than ever before.

Different eye health problems and technologies used to treat them

There are many eye health issues that technology has helped improve. Here are some of the most common:

Myopia

Nearsightedness, also known as nearsightedness, is a condition in which people can see near objects clearly but have difficulty seeing far objects. This is because the eyeball is too long or the cornea (the transparent front surface of the eye) is too curved. Myopia affects approximately 30% of the population.

Hyperopia

Farsightedness, also known as farsightedness, is a condition in which people can see distant objects clearly but have difficulty seeing objects close to them. This is because the eyeball is too short or the cornea (the transparent front surface of the eye) is too flat. Hyperopia affects approximately 12% of the population.

Astigmatism

Astigmatism is a condition in which the eyeball is oval in shape instead of round. This causes light to bend in different directions, resulting in blurred vision. Astigmatism affects approximately 18% of the population.

Presbyopia

Presbyopia is a condition that occurs when the lens of the eye becomes less flexible over time. This makes it difficult for people to focus on objects close to them. Presbyopia usually begins around the age of 40 and affects around 75% of people over the age of 60.

There are many different types of technologies that are used to treat these conditions. Some of the most common include:

Eyeglasses

Glasses are the most common type of vision correction. They work by distorting the light that enters the eye to help people see more clearly.

Contact lenses

Contact lenses are another type of vision correction. They work by sitting on the surface of the eye and correcting the way light bends as it enters the eye.

LASIK surgery

LASIK surgery is a type of surgery used to correct vision problems. It works by changing the shape of the cornea (the transparent front surface of the eye).

PRK surgery

PRK surgery is another type of surgery used to correct vision problems. It works by removing part of the cornea (the transparent front surface of the eye).

These are just a few of the different types of technology used in optometry. As you can see, technology has played an important role in improving the optometry industry and enabling more people to have better vision. Thanks to technology, optometrists are able to provide better care than ever before.

]]>
Could you go a day without screens? Nova Scotia Sight Group Issues Challenge https://web-xpress.com/could-you-go-a-day-without-screens-nova-scotia-sight-group-issues-challenge/ Sat, 19 Mar 2022 01:49:30 +0000 https://web-xpress.com/could-you-go-a-day-without-screens-nova-scotia-sight-group-issues-challenge/ With a new season approaching, the idea of ​​starting spring cleaning by tackling screen time habits is something the Maritimers admit is easier said than done. “I think if I could go 24 hours without my phone I would feel a lot better about myself and be really proud,” said Kate Morrison, a grade 12 […]]]>

With a new season approaching, the idea of ​​starting spring cleaning by tackling screen time habits is something the Maritimers admit is easier said than done.

“I think if I could go 24 hours without my phone I would feel a lot better about myself and be really proud,” said Kate Morrison, a grade 12 student at the Breton Education Center in Cape Breton.

And she’s not opposed to taking a break.

“I’m busy most of the time with school activities, so I don’t spend too much time on my phone anyway.”

But it looks like Morrison is in the minority.

Doug Earle is part of Fighting Blindness Canada, an organization that launched a challenge called “Screens off For Sight” this weekend.

Earle says it’s partly to combat bad phone habits built during the pandemic.

He says Statistics Canada data shows screen time has increased by around 60% during COVID-19.

“Well, it’s a 24-hour challenge we’re issuing to all Canadians to turn off the screens,” Earle explained.

He says that during the pandemic, children, in particular, were spending an average of two more hours a day on screens, largely due to online learning.

Something the eye specialists his group consults with say can be bad for a person’s eyesight over time.

“They report in the work they do that about 90% of adults experience eye strain,” Earle said. “Consistent eye strain over time leads to eye health issues.”

For the younger generation who have been around screens most of their lives, you’d think it might be harder to quit smoking, even for a day.

But other high school students CTV News spoke to thought they would be up to the task.

“I try to limit my screen time, but I’ve never tried to take a full day off,” said Isabella White, also a student at the Breton Education Centre. “It would be difficult, but I think maybe I could do it.”

As to whether Earle views the idea of ​​24 hours without screen time as a difficult challenge, he was candid in his response.

“My hand is shaking just thinking about it. Because we’re so addicted to our phones and TV, computer games.”

The 24-hour Screens Off for Sight challenge begins when the phones go off at 6 p.m. Saturday

]]>
WORLD GLAUCOMA WEEK: LASG organizes an awareness walk and a free eye pressure check https://web-xpress.com/world-glaucoma-week-lasg-organizes-an-awareness-walk-and-a-free-eye-pressure-check/ Thu, 10 Mar 2022 13:52:11 +0000 https://web-xpress.com/world-glaucoma-week-lasg-organizes-an-awareness-walk-and-a-free-eye-pressure-check/ Regular eye checks will prevent irreversible blindness that can be caused by glaucoma and other blinding conditions. The LAGOS State Department of Health organized an awareness walk and free eye pressure check to commemorate World Glaucoma Week of the year 2022 in Lagos from Sunday March 6 to Sunday March 12, 2022. The Lagos State […]]]>

Regular eye checks will prevent irreversible blindness that can be caused by glaucoma and other blinding conditions.

The LAGOS State Department of Health organized an awareness walk and free eye pressure check to commemorate World Glaucoma Week of the year 2022 in Lagos from Sunday March 6 to Sunday March 12, 2022.

The Lagos State government also took the opportunity to warn citizens to avoid associating with unqualified eye health personnel, adding that regular eye checks will prevent irreversible blindness that can be caused by glaucoma and d other blinding conditions.

Speaking after the sensitization march, the Permanent Secretary of the Ministry of Health, Dr Olusegun Ogboye explained that the patronage of unqualified eye health professionals for eye care services is contrary to the efforts made by the government and relevant stakeholders to reduce the prevalence of preventable diseases. blinding eye conditions.

Dr Ogboye noted that the theme for World Glaucoma Week 2022, “The world is bright, save your sight”, highlights the need for citizens to take responsibility and take good care of their lives. eyes to prevent visual impairment and irreversible blindness caused by Glaucoma and other blinding eye conditions.

He said: “The eye is a very delicate organ in the body that requires proper attention and treatment by licensed eye health professionals. The eye is such a precious gift for all human beings and it is something that we need to pay special attention to. I would tell anyone who patronizes quacks for their eye health care that they need to re-evaluate the importance of their eyes. I know how important my eyes are to me, and I certainly won’t subject them to just anyone to look at them, and I certainly won’t insert any fluids or medications that aren’t recommended.

Dr Ogboye said the awareness walk organized by the Department of Health to commemorate this year’s World Glaucoma Week aims to raise awareness and awareness of the dangers of glaucoma as a silent killer of sight.

Along the same lines, Consultant Ophthalmologist and Director of Medical Administration, Training and Programs at the Ministry of Health, Dr. Funmilayo Shokunbi explained that blindness caused by glaucoma is irreversible and incurable. , but can be successfully managed if detected early enough.

Emphasizing the need for regular eye check-ups as a preventive measure against glaucoma, Dr. Shokunbi noted that citizens over the age of 40, whose family members have glaucoma, have high intraocular (eye) pressure or have had an eye injury or surgery. are at risk for glaucoma.

The ophthalmologist further revealed that the Ministry of Health is arranging free eye screenings and intraocular pressure checks for public servants including members of the Lagos State Executive Council, the body of permanent secretaries as well as officials as part of the week-long Global Glaucoma Commemoration activities in Lagos State.

]]>
200 new jobs at Johnson & Johnson in Limerick https://web-xpress.com/200-new-jobs-at-johnson-johnson-in-limerick/ Wed, 09 Mar 2022 06:02:15 +0000 https://web-xpress.com/200-new-jobs-at-johnson-johnson-in-limerick/ Johnson & Johnson Vision, which manufactures eye health products at its Limerick factory, will create work for 200 additional staff over the next three years. Recruitment has begun to hire an additional 120 people spread across Johnson & Johnson’s laboratories, automation, engineering and quality control areas. A further 80 people are expected to be employed […]]]>

Johnson & Johnson Vision, which manufactures eye health products at its Limerick factory, will create work for 200 additional staff over the next three years.

Recruitment has begun to hire an additional 120 people spread across Johnson & Johnson’s laboratories, automation, engineering and quality control areas.

A further 80 people are expected to be employed on the construction of an extension to the Limerick plant.

Johnson & Johnson Vision already employs 1,600 people at its Castletroy factory – it is the company’s largest global manufacturing facility for its contact lens business.

It is investing 35 million euros there, allowing it to expand its product portfolio for intraocular lenses, used in cataract surgery.

This device will replace the eye’s natural lens, improving outcomes for people whose sight may become impaired or who develop blindness if left untreated.

Over 4,500 people in Ireland were waiting for cataract surgery last year, and while that figure is down from over 5,500 in 2019, several hundred are waiting over 18 months for this corrective surgery and that is changing often life.

John Fitzgibbon, chief operating officer, said Johnson & Johnson is committed to helping people with cataracts and changing global statistics for people with eye health issues.

Mary Buckley, Executive Director of IDA Ireland, said: “The availability of a highly talented and skilled workforce in Ireland has enabled Johnson & Johnson’s ambitious expansion plans.

Niall Collins, Minister of State at the Department of Further and Higher Education, Research, Innovation and Science, welcomed the investment.

He said: “Creating 200 new jobs for the region also proves that we can provide a talented and skilled workforce ready to tackle some of the greatest challenges facing society.”

]]>
Vision screenings detect troubling health conditions throughout the body https://web-xpress.com/vision-screenings-detect-troubling-health-conditions-throughout-the-body/ Sun, 06 Mar 2022 08:00:00 +0000 https://web-xpress.com/vision-screenings-detect-troubling-health-conditions-throughout-the-body/ Diabetes and high blood pressure are among the most common hidden health conditions detected during eye exams. Steinemann said diabetes is of particular concern because of the growing death toll and the potential for significant vision loss and other serious complications. According to the Centers for Disease Control, of the 29.1 million people with diabetes […]]]>

Diabetes and high blood pressure are among the most common hidden health conditions detected during eye exams. Steinemann said diabetes is of particular concern because of the growing death toll and the potential for significant vision loss and other serious complications.

According to the Centers for Disease Control, of the 29.1 million people with diabetes in the United States, 27.8% are undiagnosed. Another 86 million Americans have prediabetes, which can be reversed with early intervention.

“Some of them may come to us with blurred vision; other times there are no symptoms. But we can see those tale shifts in the eyes,” Steinemann said.

If left untreated, the high blood glucose levels associated with diabetes can damage the blood vessels in the eye and lead to visual impairment and even blindness. Diabetes also wreaks havoc on other organs, putting diabetics at a much higher risk of cardiovascular and kidney disease and premature death.

Meanwhile, the CDC estimates that one in three American adults with high blood pressure, or hypertension, don’t know they have it. Uncontrolled high blood pressure increases the risk of heart disease, stroke and dementia. As with diabetes and prediabetes, knowing you have high blood pressure — often called the “silent killer” — is the first step in fighting its progression. An eye exam can reveal undiagnosed hypertension by identifying thickening of the blood vessels, as well as other signs of damage.

Steinemann predicts that vision screenings will become increasingly critical as we uncover links between eye health and overall well-being — some of which are already coming to light.

A substantial 2021 study, for example, found that people with two or more systemic diseases (such as diabetes, cardiovascular disease, and/or depression) in addition to an ophthalmic condition (macular degeneration, cataracts, and/or or diabetic eye disease) were at higher risk of dementia. The increased risk was most pronounced in participants with diabetes-related eye disease, whose risk of dementia was 61% higher than participants who did not have an ophthalmic problem.

“We’re also learning that cataract surgery can ward off dementia,” Steinemann said. “A very interesting study that was just published last month that took place at the University of Washington and followed over 3,000 patients for eight years found that patients who had cataract surgery had a reduced risk of dementia by 30%.

]]>
Nicox Partner Fera Pharmaceuticals Obtains Orphan Drug https://web-xpress.com/nicox-partner-fera-pharmaceuticals-obtains-orphan-drug/ Wed, 02 Mar 2022 06:30:00 +0000 https://web-xpress.com/nicox-partner-fera-pharmaceuticals-obtains-orphan-drug/ March 2n/a2022 – release at 7:30 CET Sophia-Antipolis, France Nicox S.A. (Euronext Paris: FR0013018124, COX), an international society of ophthalmology, and Fera Pharmaceuticals, a private US specialty pharmaceutical company, today announced that the US Food and Drug Administration (FDA) has granted Orphan Drug Designation to naproxcinod for the treatment of sickle cell disease, which affects […]]]>

March 2n/a2022 – release at 7:30 CET
Sophia-Antipolis, France

Nicox S.A. (Euronext Paris: FR0013018124, COX), an international society of ophthalmology, and Fera Pharmaceuticals, a private US specialty pharmaceutical company, today announced that the US Food and Drug Administration (FDA) has granted Orphan Drug Designation to naproxcinod for the treatment of sickle cell disease, which affects approximately 100,000 Americans. Naproxcinod is a nitric oxide (NO)-donating naproxen combining the cyclooxygenase (COX) inhibitory activity of naproxen with that of nitric oxide developed by Nicox and licensed exclusively to Fera in the United States. Nicox has tested naproxcinod in more than 2,700 patients with osteoarthritis, generating a significant body of clinical safety data that is available to support Fera’s development of naproxcinod and ultimately a New Drug Application submission for sickle cell disease.

“We congratulate Fera on obtaining Orphan Drug Designation for naproxcinod, which is a very important step to be able to develop this molecule as a potential treatment for sickle cell disease. Fera has already carried out pre-clinical development work on naproxcinod in sickle cell disease models, and the extensive clinical package already developed by Nicox positions the molecule, the first to go into clinical development by our company – for accelerated development.noted Michele Garufi, CEO and President of Nicox.

“Wwe are extremely happy this the FDA granted orphan drug status to naproxcinod because it now allows us to continue our development for sickle cell disease with the benefits that come with that designation. noted Frank DellaFera, founder and CEO of Fera Pharmaceuticals.

Aon orphan drug designation

The FDA’s Orphan Drug Designation program grants orphan drug status to drugs and biologics intended for the safe and effective treatment, diagnosis, or prevention of rare diseases that affect fewer than 200,000 people in the United States. Benefits of orphan drug designation in the United States include seven years of market exclusivity after FDA approval, waiver or partial payment of application fees, and tax credits for trial-related expenses. qualified clinics conducted after receipt of orphan designation.

Role of nitric oxide in sickle cell disease

Sickle cell disease is an inherited condition that affects red blood cells, with a faulty version of hemoglobin causing normally oval-shaped red blood cells to take on a sickle shape, leading to symptoms such as pain, frequent infections and anemia. Rupture of these cells into the bloodstream can lead to inflammation, reduced NO and subsequent thickening of the endothelial cell wall, as well as platelet activation. In this inflamed and reduced-volume environment, sickle-shaped red blood cells, leukocytes (white blood cells) and activated platelets aggregate to create a “vascular jam” (vaso-occlusion), leading to a painful vaso-occlusive crisis.

Nicox-Fera partnership

Naproxcinod, a cyclooxygenase inhibitor (CINOD) nitric oxide (NO) donating naproxen, is a nonsteroidal anti-inflammatory product candidate designed to release NO and naproxen, originally discovered and developed by Nicox. Nicox and Fera entered into an agreement in December 2015, amended in September 2018 and December 2020, which granted Fera exclusive rights to develop and commercialize naproxcinod for the US market. Nicox is eligible to potentially receive a one-time $40 million sales-based milestone if naproxcinod reaches $1 billion in annual sales (for any indication) in the United States as well as 7% royalties on future net sales of naproxcinod in the United States. Fera is responsible for all clinical development, manufacturing, regulatory, and commercialization activities in the United States.

Nicox retains all rights to naproxcinod outside of the United States, subject to payment of royalties to Fera, if intellectual property developed under the agreement is used outside of the United States

Nicox SA is an international ophthalmology company developing innovative solutions to help maintain vision and improve eye health. Nicox’s lead clinical development program is NCX 470, a novel nitric oxide-donating prostaglandin analog intended to reduce intraocular pressure in patients with open-angle glaucoma or ocular hypertension. The company is also developing NCX 4251, a proprietary formulation of fluticasone, for dry eye. Nicox derives revenue from VYZULTA® in glaucoma, under exclusive worldwide license to Bausch + Lomb, and ZERVIATE® in allergic conjunctivitis, under license in several geographies, including Eyevance Pharmaceuticals, LLC, in the United States and Ocumension Therapeutics in China and the majority of Southeast Asian markets.

Nicox is headquartered in Sophia Antipolis, France, is listed on Euronext Paris (Compartment C: Mid Caps; Ticker: COX) and is part of the CAC Healthcare, CAC Pharma & Bio and Next 150 indices.

For more information about Nicox, its products or its pipeline, please visit: www.nicox.com.

The information contained in this document is subject to change without notice. This information includes forward-looking statements. These forward-looking statements are not guarantees of future performance. These statements are based on the current expectations or beliefs of the management of Nicox SA and are subject to a number of factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Nicox SA and its affiliates, directors, officers, employees, advisors or agents, do not undertake and have no obligation to provide any updates or revise any forward-looking statements.

The risk factors likely to have a significant effect on Nicox’s business are presented in the 3rd chapter of ‘Universal registration document, annual financial report and management report 2020‘ filed with the French Financial Markets Authority (AMF) on March 1, 2021 and in the 2n/a chapter of the amendment to the “Universal Registration Document, annual financial report and management report 2020» filed with the AMF on December 9, 2021 which are available on the Nicox website (www.nicox.com).

]]>
Study to improve eye health and progress towards development goals https://web-xpress.com/study-to-improve-eye-health-and-progress-towards-development-goals/ Sun, 27 Feb 2022 14:23:20 +0000 https://web-xpress.com/study-to-improve-eye-health-and-progress-towards-development-goals/ In 2020, 1.1 billion people were living with untreated visual impairment and this figure is expected to rise to 1.8 billion by 2050. Despite progress in recent years against certain infectious diseases, millions continue to live unnecessarily with visual impairment. visual impairment and blindness. 90% of people with these conditions live in low- and middle-income […]]]>

In 2020, 1.1 billion people were living with untreated visual impairment and this figure is expected to rise to 1.8 billion by 2050. Despite progress in recent years against certain infectious diseases, millions continue to live unnecessarily with visual impairment. visual impairment and blindness. 90% of people with these conditions live in low- and middle-income countries, and visual impairment disproportionately affects women, rural populations and ethnic minority groups.

The study and research was conducted as part of the Lancet Global Health Commission on Global Eye Health collaboration. A total of 226 studies were reported on the relationship between an eye health service and SDG-related outcomes or pathways. These services include cataract surgery, free cataract screening, eyeglass delivery, trichiasis surgery, rehabilitation services and rural community eye health volunteers.

Professor Matthew Burton, Director of ICEH at LSHTM, said: “Ocular health is often overlooked, but it is an important factor in improving overall health and quality of life. Our study, which is one of only two studies to examine the links between improvements in a specific area of ​​health and the SDGs, demonstrates that eye health is a powerful enabler for sustainable development, both directly and indirectly.

“Currently, eye health does not feature in any of the many SDG targets and monitoring indicators. This study is part of a growing body of evidence that eye health policies should be integrated into education, the workplace and social services.Interventions, such as improving access to eyeglasses and cataract surgery, must be prioritized and given the financial support that a challenge of this magnitude deserves.

The authors found several direct links between eye health services and one or more of the seven SDGs, including:

  • Better eye health reduces poverty (SDG 1) and improves productivity (SDG 8)
    Numerous studies have shown that access to eye health interventions increases productivity, housing costs and household income. In the Philippines, for example, the per capita cost of cataract surgery has increased by 88% in one year.
  • Better eye health improves overall health and well-being (SDG 3)
    Additional reviews of this study carried out for the Commission show the link between visual impairment and mortality, falls, dementia, mental health problems, heart disease, respiratory disease and cancer.
  • Better eye health improves educational outcomes (SDG 4)
    Good vision is associated with better school results. Giving glasses can improve academic exam results, a study in China shows that giving glasses reduces the chance of failing a class by 44%.
  • Better eye health advances equality (SDGs 5 and 10)
    Interventions such as training and cataract surgery for rural community eye health volunteers can reduce gender inequities in attendance and treatment. Similarly, income equality has been improved through cataract surgery.
  • Better eye health reduces road accidents (SDG 11)
    It has been found that the incidence of cataract-related conflict is 2.5 times higher. Studies show that cataract surgery can reduce the risk of road and motor vehicle accidents.

A total of 27 studies reported that eye health services had a positive effect on the progress of one or more SDG targets, and indirect effects were proposed for all targets. Cataract surgery and eyeglasses were interventions with a large number of studies reporting beneficial effects on SDG.

The potential human impact of not including eye health among the SDG targets will not only affect individuals, but also communities as well as nations as a whole. Vision is a primary sense that enables people to live, work and contribute to communities to their full potential. It is urgent that the right vision be prioritized in the right way.

Her Excellency, Dr Aubrey Webson, Permanent Representative to the United Nations for Antigua and Barbuda and Chair of the United Nations Friends of Vision group, said: “No one should have to live with preventable blindness or disability. addressable visual in the 21st century, as we have proven low-cost solutions to meet these conditions. The SDGs represent the highest ambition of the global community, and it is time for eye health to be recognized as an integral part of that.

Source: Medina

Stay connected with us on social media platform for instant update, click here to join our Jwitter& Facebook

]]>
Prairie Fare: Refresh your eyes with winter nutrition | Columnists https://web-xpress.com/prairie-fare-refresh-your-eyes-with-winter-nutrition-columnists/ Sat, 26 Feb 2022 07:00:00 +0000 https://web-xpress.com/prairie-fare-refresh-your-eyes-with-winter-nutrition-columnists/ “Look at all that snirt!” exclaimed my husband. Our deep snowbanks were covered in dirt (“snirt”), thanks to strong winds. “I’m so sick of winter,” I replied. He glanced in my direction. I read his mind. “That’s an understatement,” he thought. As we rode that windy day, our world looked like a black and white […]]]>

“Look at all that snirt!” exclaimed my husband.

Our deep snowbanks were covered in dirt (“snirt”), thanks to strong winds.

“I’m so sick of winter,” I replied.

He glanced in my direction. I read his mind.

“That’s an understatement,” he thought.

As we rode that windy day, our world looked like a black and white movie. Luckily, a colorful car or house punctuated the dark color of the exterior.

Like everyone else, I’m waiting for the snow to melt and the snirt to return to the lawns and gardens.

Blades of green grass and tree leaves will be a welcome sight.

We can definitely brighten our days by bringing the color of nature into our kitchens any season of the year. The natural pigments contained in food have beneficial effects on health. In fact, we can help maintain our eyesight and prevent eye disease through our food choices.

People also read…

You might think of carrots and their association with eye health. Carrots and other dark orange and golden vegetables are a healthy option linked to reducing our risk of night blindness. Leafy greens and other colorful foods are more often linked to protecting eyesight.

You may know someone with age-related macular degeneration. This is the deterioration of the central region of the retina called the macula. The “macula” is a region near the optic nerve at the back of our eyes that allows us to see clearly and distinguish colors.

Macular degeneration is one of the main causes of blindness, and scientists have discovered that diet can play a role in preventing this eye disease.

The macula lutea (Latin for “yellow spot”) is made up of lutein and zeaxanthin. We literally feed our eyes with our food. These pigments are found in colorful fruits and vegetables.

Lutein and zeaxanthin are carotenoids from the same group as the familiar beta-carotene found in carrots.

Kale, collard greens and spinach, orange peppers and corn are good sources of zeaxanthin.

Kale, green leafy vegetables, spinach, corn, peas, and yellow and orange vegetables are good sources of lutein. Egg yolks are another great source of lutein.

When enjoying an omelette or scrambled eggs, chop some bell peppers and add chopped spinach or kale to double your eye-healthy pigments.

If you’re a gardener, consider planting vegetables that promote good eye health.

Inspire your gardening with programs offered by NDSU Extension and other extension organizations across the country.

To see www.ag.ndsu.edu/fieldtofork for information on signing up for our “Field to Fork” series, as well as links to many resources.

You don’t have to wait for a farmers market or your own garden. Enjoy colorful produce every day in the produce aisle, freezer section or canning aisle. All forms of vegetables and fruit count towards the recommendations: at least 2 1/2 cups of vegetables and 2 cups of fruit daily for most adults and children.

You can see eye health supplements in the store, and some supplements have shown health benefits, especially for those who lack fruits and vegetables in their diet. Do your homework on supplements and always tell your health care provider which supplements you are taking.

However, aim for healthy foods before you drop bottles of supplements in your shopping cart.

Consider these tips from the National Eye Institute to www.nei.nih.gov support your vision.

See an eye care professional regularly. If you are 50 or older, have a dilation eye exam annually or as recommended by an eye care professional. Age-related macular degeneration, cataracts, diabetic retinopathy and glaucoma can be detected by regular eye exams.

If you smoke, take steps to quit.

Practice regular physical activity.

Maintain normal blood pressure. Do you know your numbers?

Wear sunglasses and a wide-brimmed hat when outdoors in direct sunlight.

Wear safety glasses when working around your home or playing sports.

This colorful recipe is a feast for our eyes and nourishment for our bodies.

Good for your eyes Roasted vegetables

2 cups sweet potatoes, cut into small cubes

1 red bell pepper, chopped

1 yellow squash, sliced ​​and quartered

1 zucchini, sliced ​​and quartered

2 tablespoons balsamic vinegar

2 teaspoons Italian seasoning

salt and pepper to taste)

Preheat oven to 425 F. Line a baking sheet with foil. Place the sweet potatoes in a bowl and add 1 tbsp olive oil, 1 tbsp balsamic vinegar, 1 tsp Italian seasoning, and salt and pepper to taste. Mix to combine. Transfer the vegetable mixture (reserve bowl) to a baking sheet and spread in a single layer. Cook for about 30 minutes, then stir. Place the remaining vegetables in a bowl and add the remaining olive oil, balsamic vinegar, garlic and Italian seasoning. Season with salt and pepper to taste. Mix to combine. Add to sweet potatoes on a plate. Roast 10 to 15 minutes longer or until tender. The roasting time may need to be adjusted depending on the size of the vegetables. Serve immediately. Note: Feel free to experiment with different vegetables or different seasoning blends.

Makes 12 servings. Each serving contains 80 calories, 1 gram (g) of fat, 2 g of protein, 10 g of carbohydrates, 2 g of fiber and 30 milligrams of sodium.

Julie Garden-Robinson is an NDSU Extension Food and Nutrition Specialist and Professor.

]]>
5 Best Opticians in Anaheim, CA https://web-xpress.com/5-best-opticians-in-anaheim-ca/ Thu, 24 Feb 2022 15:03:44 +0000 https://web-xpress.com/5-best-opticians-in-anaheim-ca/ Below is a list of the best and leading opticians in Anaheim. To help you find the best opticians located near you in Anaheim, we’ve compiled our own list based on this rating point list. The best opticians in Anaheim: The top rated Opticians in Anaheim, CA are: Glasses optometry – provide the highest quality […]]]>

Below is a list of the best and leading opticians in Anaheim. To help you find the best opticians located near you in Anaheim, we’ve compiled our own list based on this rating point list.

The best opticians in Anaheim:

The top rated Opticians in Anaheim, CA are:

  • Glasses optometry – provide the highest quality eye care
  • Eye Vista Optometry – strive to put the interests of their patients first
  • Downtown Anaheim Family Optometry – offer a wide range of optometry services
  • Precision Vision Optometry – Anaheim – All their doctors are TMOD certified
  • Anaheim Eye Care Optometry – provide thorough eye exams

Glasses optometryOpticians in Anaheim

Glasses optometry always strives to offer the best technology and it starts before you even walk into their office. You can electronically complete any questions they need to know before your visit. They offer a wide range of services from comprehensive eye exams for patients of all ages to contact lens exams, dry eye exams, glaucoma management and medical checkups for any emergency that may occur. Their professional goal is to provide the highest quality eye care to every patient they see.

Their comprehensive exam uses state-of-the-art technology testing your eyes for proper prescription and neurological integrity, evaluating all eye diseases including glaucoma, cataracts and macular degeneration. They also strive to give back as much as they can, whether by donating eyewear, partnering with generous frame lines, or hosting school screenings and veteran exams.

Products:

Comprehensive eye exams, digital retinal assessments, contact lens evaluations, and more.

LOCATION:

Address: 5655 E La Palma Ave Suite 150, Anaheim Hills, CA 92807
Call: (714) 340-0520
Website: www.spectacleoptometry.com

COMMENTS:

“It was the first time I came here and I’m delighted! The office is absolutely adorable and spotless. Dr. Bovy did a thorough examination and explained everything to me. They have a wonderful selection of glasses, I love my new glasses! Thank you Dr Bovy, I will definitely come back.” -Susan W.

Eye Vista OptometryBest Opticians in Anaheim

Eye Vista Optometry offers a variety of vision services, ranging from comprehensive eye exams to custom eyeglasses and custom contact lens fitting. With special training in low vision rehabilitation and the use of the latest technology, Dr. Tran accurately diagnoses, treats and manages the range of medically related eye conditions such as red eye, dry eye, diabetes and low vision. They strive to put the interests of their patients first and educate them about their eye health and well-being.

Products:

Low vision rehabilitation, Glasses, Professional glasses

LOCATION:

Address: 1092 N State College Blvd, Anaheim, CA 92806
Call: (714) 635-8671
Website: www.eyevistaanaheim.com

COMMENTS:

“They have better frames than most places and have the best prices. Don’t waste time looking for prescription eyes or sunglasses, check out these guys. – Howie G.

Downtown Anaheim Family OptometryAnaheim Opticians

Downtown Anaheim Family Optometry, formerly the practice of Dr. Hershel Welton OD. Their team of professionals is dedicated to providing their patients with the highest quality optometry care. They offer a wide range of optometry services so that all of your family’s needs are met under one roof. Their goal is for you to leave their office with an unforgettable and enjoyable experience, which is why their welcoming and compassionate staff will go out of their way to make you feel at home.

Part of alleviating your concerns is explaining what you can expect from their practice. When you are new to their office, they strive to provide you with a positive and comforting experience. Once you’ve been with them for a while, you can continue to expect the highest level of service.

Products:

Comprehensive eye exams, contact lenses, glaucoma, myopia control

LOCATION:

Address: 303 W Lincoln Ave Suite #120, Anaheim, CA 92805
Call: (714) 535-8404
Website: www.anaheimfamilyoptometry.com

COMMENTS:

“Super friendly staff and great selection of frames. Dr. Shu gave me a thorough eye exam, answered all of my questions/concerns, and was very personable. There was also plenty of parking space and the office was clean. – Linda K.

Precision Vision Optometry – AnaheimGood opticians in Anaheim

Precision Vision Optometry – Anaheim is delighted to provide you with professional eye care services in a comfortable and friendly environment. Precision Vision Optometry has two full-service facilities open seven days a week. Whether it’s time for your comprehensive eye exam or you need a contact lens fitting, they’ve got you covered. All of their doctors are TMOD certified, which means they can detect and treat many eye diseases and conditions.

Their infirmaries have more than 5,000 spectacle frames and 2,000 contact lenses in stock. They have one of the largest selections of frames fully covered by VSP and other vision insurance. They offer frames of all shapes, colors, sizes, brands and prices. They love kids and have plenty of durable, affordable and fun frames for them.

Products:

One-hour service on eyeglasses and contact lenses, free consultations on laser vision correction, and more.

LOCATION:

Address: 661 N Euclid St, Anaheim, CA 92801
Call: (714) 817-0606
Website: www.precisionvisionoptometry.com

COMMENTS:

“The staff are excellent and they don’t try to sell you. They work with your insurance and your budget. I can’t believe a reviewer gave me 1 star because she’s been going there for years. Everyone is having a bad day. I can say this place is not perfect but they are professional.” – Michelle R.

Anaheim Eye Care OptometryOne of the best opticians in Anaheim

Anaheim Eye Care Optometry, their mission is to give comprehensive eye assessments in a family setting, with an emphasis on excellent customer service. They strive to provide thorough eye exams focused on preventing eye disease and educating their patients about healthy eye care. They provide extraordinary eyewear to fit any active lifestyle. They are also subgenres in medical optometry such as red eye, ocular diabetes, glaucoma, cataracts, and hard-to-fit contacts.

They strive to educate people on the importance of annual checkups to prevent and control eye disease. Anaheim Eye Care Optometry provides community outreach by meeting with local leaders, attending health fairs, participating in religious events, administering school screenings, and working alongside other physicians to promote eye care.

Products:

Comprehensive eye exam, contact lens fitting and follow-up, dilated fundus examination, eyeglass fitting

LOCATION:

Address: 947 S Anaheim Blvd #230, Anaheim, CA 92805
Call: (714) 491-0881
Website: www.anaheimeyecare.net

COMMENTS:

“I went for a contact lens fitting and it was a great experience with Dr. Vargas. I am happy with the results. – Edward B.

]]>
Dompé announces the enrollment of the first patient in the phase 3 trial of cenegermin in patients with severe dry eye disease related to Sjögren’s disease https://web-xpress.com/dompe-announces-the-enrollment-of-the-first-patient-in-the-phase-3-trial-of-cenegermin-in-patients-with-severe-dry-eye-disease-related-to-sjogrens-disease/ Wed, 09 Feb 2022 18:29:00 +0000 https://web-xpress.com/dompe-announces-the-enrollment-of-the-first-patient-in-the-phase-3-trial-of-cenegermin-in-patients-with-severe-dry-eye-disease-related-to-sjogrens-disease/ – Two multicenter Phase 3 clinical trials will evaluate the safety and efficacy of cenegermin in patients with severe dry eye disease related to Sjögren’s disease – The Eye Research Foundation in Newport Beach, California is one of more than 10 clinical trial sites in the United States and Europe – Dompé partners with the […]]]>

– Two multicenter Phase 3 clinical trials will evaluate the safety and efficacy of cenegermin in patients with severe dry eye disease related to Sjögren’s disease

– The Eye Research Foundation in Newport Beach, California is one of more than 10 clinical trial sites in the United States and Europe

– Dompé partners with the Sjögren Foundation to improve understanding of the disease and provide information on opportunities to participate in clinical research.

Milan, Italy and SAN MATEO, California, February 9, 2022 /PRNewswire/ — Dompé farmaceutici SpA and Dompé US Inc. (collectively Dompé) announced today that the first patient has been enrolled in its Phase 3 clinical trial to evaluate the efficacy and safety of cenegermine in patients with severe Sjögren’s dry eye, a primary symptom of Sjögren’s disease, which is often underdiagnosed1. This trial is part of a program that includes two randomized, double-blind, vehicle-controlled studies that will be conducted at more than 10 sites in the United States and Europe, 2.3 and was initiated following encouraging data from a phase 2 study, the results of which will be shared at an upcoming medical meeting. This study evaluated the efficacy and safety of cenegermin ophthalmic solution versus vehicle in patients with moderate to severe dry eye disease, including a subset of patients diagnosed with Sjögren’s disease without associated rheumatic disease. . 8

(PRNewsfoto/Dompé Farmaceutici SpA)

Sjögren’s disease (pronounced SHOW-grins) is an autoimmune disease that can affect many parts of the body. In patients who are affected, the body’s white blood cells attack certain glands, including those that provide lubrication to our eyes and mouth. Therefore, dry eye is common in people living with Sjögren’s disease.1. Dry eyes associated with Sjögren’s disease can lead to vision problems including light sensitivity, blurred vision and corneal damage4.

“The majority of Sjögren’s patients live with dry eye, and many of these patients will experience eye symptoms which can often be quite severe,” said Jeannet church, CEO of the Sjögren Foundation. “We are grateful for Dompé’s commitment to research that may lead to new treatment options for people with Sjögren’s disease who suffer from dry eye disease and we encourage people to speak to their doctor to learn more. on participation in clinical trials.

There are currently no FDA-approved treatments for Sjögren’s severe dry eye disease; it is managed by replacing moisture at the affected glandular sites and suppressing the autoimmune response locally as well as systemically1.

“With cenegermin, Dompé has led the way, leveraging decades of research to better understand how nerve growth factor (NGF) contributes to overall eye health.” noted Melissa Toyos, MD, Principal Investigator and Partner and Director of Research at Toyos Clinic. “Studies have demonstrated a neurosensory component in certain types of dry eye, suggesting that cenegermin could be an innovative option for these patients.” 9

The NGF0121 study (NCT 05133180) will enroll 100 patients and will use the Schirmer test and Symptom Assessment Questionnaire in Dry Eye (SANDE) as primary endpoints to measure improvement in signs and symptoms of dry eye over time.2. The NGF0221 study (NCT 05136170) will enroll 48 patients who are currently being treated for severe Sjögren-related dry eye with cyclosporine A3 and will use Schirmer’s test as the sole primary endpoint3. Patients in both studies will be randomized (1:1) to receive either cenegermin ophthalmic solution 20 mcg/mL or vehicle three times daily. 2.3.

“These studies illustrate our commitment to exploring how NGF science can innovate for eye diseases with unmet medical need.” noted Ashley KlinGlobal Head of Biotechnology, Dompé Farmaceutici SpA and Managing Director, Dompé US Inc. lasting effect impact on ocular tissue and help restore the natural homeostasis of the eye.” ten

For more information or a list of sites for ongoing clinical trials evaluating the safety and efficacy of cenegermin in patients with severe Sjögren’s dry eye, contact usmedinfo@dompe.com or visit www.clinicaltrials .gov.

About Oxervate® (cenegermin-bkbj ophthalmic solution)

Oxervate is a 0.002% cenegermin-bkbj (20 mcg/mL) topical solution currently approved by the FDA for the rare disease neurotrophic keratitis (NK). Its active ingredient cenegermin-bkbj, is a recombinant form of human nerve growth factor and is structurally identical to the NGF protein made naturally by the body5, 6. Nerve growth factor (NGF) is involved in the differentiation and maintenance of neurons which acts through specific high and low affinity receptors in the anterior segment of the eye to support the innervation and integrity of the cornea.seven

Oxervate is not yet FDA approved for the treatment of severe dry eye disease related to Sjögren’s disease. More information about Oxervate for Neurotrophic Keratitis can be found in the full product prescribing information: www.oxervate.com

Important Safety Information

Contact lenses should be removed prior to application of OXERVATE as the presence of a contact lens (therapeutic or corrective) could theoretically limit the delivery of cenegermin-bkbj to the area of ​​corneal injury. The lenses can be reinserted 15 minutes after administration.

OXERVATE may cause mild to moderate eye discomfort such as eye pain during treatment. The patient should be advised to contact their physician in the event of a more serious eye reaction.

The most common adverse reaction in clinical trials that occurred more frequently with OXERVATE was eye pain (16% of patients). Adverse effects included corneal deposits, foreign body sensations in the eye, ocular hyperemia (enlargement of blood vessels in the whites of the eyes), swelling (inflammation) of the eye, and increased tearing (1 in 10% of patients). seven

Domped in Ophthalmology

Dompé farmaceutici SpA is a rapidly growing privately-held global biopharmaceutical company founded in Milan, Italy, with a 130-year legacy of medical innovation. For more than a decade, Dompé has been a leader in the research and development of innovative therapies based on neurotrophins, proteins derived from the Nerve Growth Factor (NGF). The company’s expertise in NGF began in ophthalmology and led to a breakthrough designation following FDA approval of Oxervate® for the rare disease, neurotrophic keratitis (NK). Ongoing research in ophthalmology includes post-marketing research on NK, studies on Sjögren’s severe dry eye, and other undisclosed programs. Dompé’s R&D is anchored in EXSCALATE, an in-house developed framework-based virtual scouting platform that leverages one of the world’s most powerful supercomputing and artificial intelligence platforms. Dompé employs more than 800 employees worldwide and maintains a business operations center in the United States in the San Francisco Bay Area as well as an R&D presence in Boston.

Forward-looking statements

This press release refers to certain information that may not coincide with expected future results. Dompé firmly believes in the soundness and reasonableness of the concepts expressed. However, certain information is subject to a certain degree of indeterminacy in relation to its research and development activities and the necessary checks to be carried out by regulatory bodies. Consequently, to date, Dompé cannot guarantee that the expected results will be consistent with the information provided above.

The references

1. Carsons SE, Patel BC. Sjogren’s syndrome. [Updated 2021 Aug 9]. In: StatPearls [Internet]. treasure island (FL): StatPearls Publishing; 2021 Jan-. Available at: https://www.ncbi.nlm.nih.gov/books/NBK431049/.

2. ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (USA). Identifier NCT05133180, Study to Evaluate the Safety and Efficacy of Oxervate® Ophthalmic Solution versus Vehicle in Sjögren’s Severe Dry Eye Disease (NGF0121); Updated on January 18, 2022 [accessed 2022 Jan 26]; [about 10 screens]. Available at: https://clinicaltrials.gov/ct2/show/NCT05133180?term=rhNGF&cond=dry+eye&draw=2&rank=5

3. ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (USA). Identifier NCT05136170, study to evaluate the safety and efficacy of Cenegermin (Oxervate®) 20 mcg/mL versus vehicle, in patients with Sjögren’s dry eye disease (NGF0221); Updated on January 18, 2022 [accessed 2022 Jan 26]; [about 10 screens]. Available at: https://clinicaltrials.gov/ct2/show/NCT05136170?term=rhNGF&cond=dry+eye&draw=2&rank=4

4. Kassan SS, Moutsopoulos HM. Clinical manifestations and early diagnosis of Sjögren’s syndrome. Arch Med Intern. 2004 Jun 28;164(12):1275-84. doi: 10.1001/archite.164.12.1275. PMID: 15226160.

5. Dompé Farmaceutici SpA (October 2019). OXERVATE™ (cenegermin-bkbj) ophthalmic solution 0.002% (20 mcg/mL): Prescribing Information Highlights. Retrieved from https://oxervate.com/wp-content/uploads/2020/05/OXERVATE_Prescribe_Information_102019.pdf [Accessed 2022 Jan 26]

6. Lambiase A, Rama P, Bonini S, Caprioglio G, Aloe L. Topical treatment with nerve growth factor for corneal neurotrophic ulcers. N Engl J Med 1998;338:1174-80.

7. OXERVATE.com. 2019. Important Safety Information – OXERVATE™ (cenegermin-bkbj) ophthalmic solution 0.002% (20 mcg/mL) HPC. [online] Available on : [Accessed 2022 Jan 26].

8. Archived Data. NGF0118

9. Villani E, Galimberti D, Viola F, Mapelli C, Ratiglia R. The cornea in Sjogren’s syndrome: an in vivo confocal study. Invest Ophthalmol Vis Sci. 2007 May;48(5):2017-22. doi: 10.1167/iovs.06-1129. PMID: 17460255.

10. Zhang X, M VJ, Qu Y et al. Managing dry eye: targeting the ocular surface microenvironment. Int J Mol Sci. 2017;18(7):1398. Published June 29, 2017. doi:10.3390/ijms18071398

Logo – https://mma.prnewswire.com/media/1743475/Dompe_Farmaceutici_Logo.jpg

Quote

Quote

See original content to download multimedia: https://www.prnewswire.com/news-releases/dompe-announces-first-patient-enrolled-in-phase-3-trial-of-cenegermin-in-patients-with -severe-sjogrens-related-dry-eye-disease-301479020.html

SOURCE Dompé Farmaceutici SpA

]]>